Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: A metabolic survival role for tumor-associated stroma

Cancer Research

Volumn 66, Issue 2, 2006, Pages 632-637

  Koukourakis, Michael I ^a   Giatromanolaki, Alexandra ^a   Harris, Adrian L ^b   Sivridis, Efthimios ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARRIER PROTEIN; GLUCOSE; GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; LACTATE DEHYDROGENASE 1; LACTATE DEHYDROGENASE 5; LACTATE DEHYDROGENASE ISOENZYME; LACTIC ACID; MONOCARBOXYLATE TRANSPORTER; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER GROWTH; CANCER SURVIVAL; CELL METABOLISM; CELL TRANSPORT; COLORECTAL CARCINOMA; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; FIBROBLAST; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA; STROMA CELL;

ADENOCARCINOMA; CELL CYCLE PROTEINS; CELL HYPOXIA; CELL PROLIFERATION; CELL SURVIVAL; COLON; COLORECTAL NEOPLASMS; ENDOTHELIAL CELLS; FIBROBLASTS; GENE EXPRESSION PROFILING; GLUCOSE; GLUCOSE TRANSPORT PROTEINS, FACILITATIVE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; ISOENZYMES; L-LACTATE DEHYDROGENASE; LACTIC ACID; MONOCARBOXYLIC ACID TRANSPORTERS; ONCOGENE PROTEINS; STROMAL CELLS;

EID: 31544445490     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-3260     Document Type: Article

References (26)

1. Macheda ML, Rogers S, Best JD. Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J Cell Physiol 2005;202:654-62.
2. Harris RA, Bowker-Kinley MM, Hyang B, Wu P. Regulation of the activity of the pyruvate dehydrogenase complex. Adv Enzyme Regul 2002;42:249-59.
3. Holbrook JJ, Liljas A, Steindel SJ, Rossman MG. Lactate dehydrogenase. In: Boyer PD, editor. The enzymes. Volume 11, 3rd ed. NY: Academic Press; 1975. p. 191-292.
4. Warburg O. On the origin of cancer cells. Science 1956;123:309-14.
5. Elstrom RL, Bauer DE, Buzzai M, et al. Akt stimulates aerobic glycolysis in cancer cells. Cancer Res 2004;64:3892-9.
6. Mottet D, Dumont V, Deccache Y, et al. Regulation of hypoxia-inducible factor-1α protein level during hypoxic conditions by the phosphatidylinositol 3-kinase/Akt/ glycogen synthase lcinase 3β pathway in HepG2 cells. J Biol Chem 2003;278:31277-85.
7. Semenza GL, Jiang BH, Leung SW, et al. Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J Biol Chem 1996;271:32529-37.
8. Edinger AL, Thompson CB. Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake. Mol Biol Cell 2002;13:2276-88.
9. Koukourakis MI, Giatromanolaki A, Sivridis E, Gatter KC, Harris AL. Pyruvate dehydrogenase and pyruvate dehydrogenase kinase expression in non small cell lung cancer and tumor-associated stroma. Neoplasia 2005;7:1-6.
10. Koukourakis MI, Giatromanolaki A, Sivridis E. Lactate dehydrogenase isoenzymes 1 and 5: differential expression by neoplastic and stromal cells in non-small cell lung cancer and other epithelial malignant tumors. Tumour Biol 2003;24:199-202.
11. Koukourakis MI, Giatromanolaki A, Sivridis E, et al. Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis. Br J Cancer 2003;89:877-85.
12. Sivridis E, Giatromanolaki A, Koukourakis MI. "Stromatogenesis" and tumor progression. Int J Surg Pathol 2004;12:1-9.
13. Giatromanolaki A, Sivridis E, Koukourakis MI. Tumour angiogenesis: vascular growth and survival. APMIS 2004;112:431-40.
14. Geschwind JF, Ko YH, Torbenson MS, et al. Novel therapy for liver cancer: direct intraarterial injection of a potent inhibitor of ATP production. Cancer Res 2002;62:3909-13.
15. Sivridis E, Giatromanolaki A, Koukourakis MI. Proliferating fibroblasts at the invading tumour edge of colorectal adenocarcinomas are associated with endogenous markers of hypoxia, acidity and oxidative stress. J Clin Pathol 2005;58:1033-8.
16. Halestrap AP, Price NT. The proton linked monocarboxylate transporter (MCT) family: structure, function and regulation. Biochem J 1999;343:281-99.
17. De Bruijne AW, Vreeburg H, Van Steveninck J. Kinetic analysis of L-lactate transport in human erythrocytes via the monocarboxylate-specific carrier system. Biochim Biophys Acta 1983;732:562-8.
18. Garcia CK, Goldstein JL, Pathak RK, et al. Molecular characterization of a membrane transporter for lactate, pyruvate, and other monocarboxylates: implications for the Cori cycle. Cell 1994;76:865-73.
19. McCullagh KJ, Poole RC, Halestrap AP, et al. Role of the lactate transporter (MCT1) in skeletal muscles. Am J Physiol 1996;271:143-50.
20. Lambert DW, Wood IS, Ellis A, Shirazi-Beechey SP. Molecular changes in the expression of human colonic nutrient transporters during the transition from normality to malignancy. Br J Cancer 2002;86:1262-9.
21. Froberg MK, Gerhart DZ, Enerson BE, et al. Expression of monocarboxylate transporter MCT1 in normal and neoplastic human CNS tissues. Neuroreport 2001;12:761-5.
22. Lu H, Forbes RA, Verma A. Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect n carcinogenesis. J Biol Chem 2002;277:23111-5.
23. Lu H, Dalgard C, Mohyedin A, McFate T, Tait AS, Verma A. Reversible inactivation of HIF-1 prolyl hydroxylase allows cell metabolism to control basal HIF-1. J Biol Chem. In press 2005.
24. De Wever O, Mareel M. Role of tissue stroma in cancer cell invasion. J Pathol 2003;200:429-47.
25. Schor SL, Schor AM. Phenotypic and genetic alterations in mammary stroma: implications for tumour progression. Breast Cancer Res 2001;3:373-9.
26. Nakagawa H, Liyanarachchi S, Davuluri RV, et al. Role of cancer-associated stromal fibroblasts in metastatic colon cancer to the liver and their expression profiles. Oncogene 2004;23:7366-77.